Advanced breast cancer treatment after CDK4/6– inhibitors - the experience of a Hospital Center

M. Costa,A.C. Valente,M. Freitas,C. Almeida,N. Tavares,D. Almeida,C. Caeiro,I. Augusto,I. Sousa,M. Barbosa

European Journal of Cancer（2022）

引用 0|浏览11

暂无评分

摘要

Background: Optimal treatment after progression under CDK4/6 inhibitors (iCDK4/6) is not yet defined, although studies are underway. The objective of this work was to evaluate the effectiveness outcomes of subsequent line to iCDK4/6 treatment in our population.

查看译文

关键词

advanced breast cancer treatment,cancer treatment,breast cancer,inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要